As of 2025-11-20, the Relative Valuation of Organogenesis Holdings Inc (ORGO) is (0.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.13 USD, the upside of Organogenesis Holdings Inc based on Relative Valuation is -113.9%.
The range of the Relative Valuation is (1.49) - 0.76 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 23.1x | 19.6x |
| Forward P/E multiples | 16.7x - 27.4x | 20.8x |
| Fair Price | (1.49) - 0.76 | (0.71) |
| Upside | -129.0% - -85.2% | -113.9% |
| Date | P/E |
| 2025-11-19 | -50.42 |
| 2025-11-18 | -54.25 |
| 2025-11-17 | -58.87 |
| 2025-11-14 | -59.95 |
| 2025-11-13 | -61.03 |
| 2025-11-12 | -63.69 |
| 2025-11-11 | -63.88 |
| 2025-11-10 | -64.28 |
| 2025-11-07 | -55.33 |
| 2025-11-06 | -38.23 |
| 2025-11-05 | -39.02 |
| 2025-11-04 | -38.13 |
| 2025-11-03 | -39.31 |
| 2025-10-31 | -41.77 |
| 2025-10-30 | -41.57 |
| 2025-10-29 | -40.98 |
| 2025-10-28 | -41.18 |
| 2025-10-27 | -42.07 |
| 2025-10-24 | -41.87 |
| 2025-10-23 | -40.39 |
| 2025-10-22 | -40.10 |
| 2025-10-21 | -40.00 |
| 2025-10-20 | -40.10 |
| 2025-10-17 | -39.71 |
| 2025-10-16 | -39.90 |
| 2025-10-15 | -40.00 |
| 2025-10-14 | -39.31 |
| 2025-10-13 | -38.82 |
| 2025-10-10 | -38.92 |
| 2025-10-09 | -39.71 |
| 2025-10-08 | -40.59 |
| 2025-10-07 | -40.69 |
| 2025-10-06 | -41.28 |
| 2025-10-03 | -42.16 |
| 2025-10-02 | -41.57 |
| 2025-10-01 | -41.67 |
| 2025-09-30 | -41.48 |
| 2025-09-29 | -41.87 |
| 2025-09-26 | -40.30 |
| 2025-09-25 | -46.00 |
| 2025-09-24 | -48.16 |
| 2025-09-23 | -46.78 |
| 2025-09-22 | -46.39 |
| 2025-09-19 | -45.01 |
| 2025-09-18 | -46.69 |
| 2025-09-17 | -45.41 |
| 2025-09-16 | -47.77 |
| 2025-09-15 | -48.75 |
| 2025-09-12 | -48.45 |
| 2025-09-11 | -49.54 |